高瀾股份(300499.SZ):未來將全力進軍電化學儲能、壓縮空氣儲能以及氫能等新型儲能賽道
格隆匯5月11日丨高瀾股份(300499.SZ)於2024年5月10日召開業績説明會,就“公司募集的資金怎麼佈局儲能温控?”,公司回覆稱,公司重視儲能液冷業務的發展,目前已有基於鋰電池單櫃儲能液冷產品、大型儲能電站液冷系統、預製艙式儲能液冷產品等技術儲備和解決方案,並擁有完整的儲能方案設計體系及營銷體系,後續公司將持續對接行業相關客户,積極進行市場拓展;公司未來將全力進軍電化學儲能、壓縮空氣儲能以及氫能等新型儲能賽道,在油氣儲運、站房式儲能領域努力實現增長,形成產業規模。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.